http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0446279-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a7f82940e47ba7a1188f8e2ffca55e0f
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-212
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-21
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-21
filingDate 1989-11-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bea1e6bb97f3acf701544fa2cbc44dc0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fbbbb04a6d92283b8d578670666602c3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_df2bf1b081a12c1bbd19ca97c918ce69
publicationDate 1991-09-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber EP-0446279-A1
titleOfInvention Treatment of squamous cell carcinoma intralesionally with recombinant human alpha interferon
abstract Human spinocellular cancer is successfully treated by intralesional administration of recombinant human alpha-2b interferon.
priorityDate 1988-12-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11046239
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID347468
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394438
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395937
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11645942
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395939
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24749
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395938

Total number of triples: 24.